SynthesisFrontiers in immunology2024

Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma.

Xu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.